tiprankstipranks
Trending News
More News >
AstraZeneca PLC (SE:AZN)
:AZN
Sweden Market
Advertisement

AstraZeneca (AZN) Income Statement

Compare
1 Followers

AstraZeneca Income Statement

Last quarter (Q2 2025), AstraZeneca's total revenue was $14.84B, an increase of 14.37% from the same quarter last year. In Q2, AstraZeneca's net income was $2.52B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 52.94B$ 46.58B$ 44.25B$ 37.11B$ 29.27B
Gross Profit
$ 39.70B$ 34.45B$ 28.04B$ 22.60B$ 21.66B
Operating Expenses
$ 27.18B$ 24.88B$ 22.99B$ 19.79B$ 16.69B
Depreciation and Amortization
$ 4.96B$ 5.02B$ 5.24B$ 4.02B$ 3.07B
EBITDA
$ 14.86B$ 13.20B$ 8.63B$ 4.59B$ 8.04B
Operating Income
$ 12.52B$ 9.57B$ 5.05B$ 2.81B$ 4.97B
Other Income/Expenses
$ -4.01B$ -2.55B$ -2.55B$ -3.07B$ -815.71M
Pretax Income
$ 8.51B$ 7.02B$ 2.50B$ -259.92M$ 4.15B
Net Income
$ 6.89B$ 6.06B$ 3.28B$ 109.85M$ 3.39B
Per Share Metrics
Basic EPS
$ 4.44$ 3.91$ 2.12$ 0.08$ 2.58
Diluted EPS
$ 4.41$ 3.88$ 2.10$ 0.08$ 2.58
Weighted Average Shares Outstanding
1.55B 1.56B 1.55B 1.42B 1.31B
Weighted Average Shares Outstanding (Diluted)
1.56B 1.56B 1.56B 1.43B 1.31B
Currency in USD

AstraZeneca Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis